Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Swiss company Dr Mueller, a leading provider of filtration equipment for pharmaceutical manufacturers worldwide, will be among the exhibitors ...

The quality and compliance of the content foundation you build today helps your organization scale efficiently in the future.

The FDA has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab ...

Dr Mueller, a Swiss supplier of filtration equipment for the global pharmaceutical industry, will be exhibiting at this year’s ...

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.

To meet growing demands amid an increasingly challenging industry landscape, a critical decision for a CRO is to ensure ...

Granite Bio has secured $100m in funding for its new antibody treatments that target several autoimmune diseases.

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...